Processing

Please wait...

Settings

Settings

Goto Application

1. WO1996003398 - HEMOREGULATORY COMPOUNDS

Publication Number WO/1996/003398
Publication Date 08.02.1996
International Application No. PCT/US1995/009158
International Filing Date 21.07.1995
Chapter 2 Demand Filed 20.02.1996
IPC
C07D 413/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
413Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
CPC
A61P 35/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
02specific for leukemia
C07D 413/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
413Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
Applicants
  • SMITHKLINE BEECHAM CORPORATION [US]/[US] (AllExceptUS)
  • BHATNAGAR, Pradip, Kumar [US]/[US] (UsOnly)
  • HEERDING, Dirk [NL]/[US] (UsOnly)
Inventors
  • BHATNAGAR, Pradip, Kumar
  • HEERDING, Dirk
Agents
  • HALL, Linda, E.
Priority Data
08/278,44821.07.1994US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) HEMOREGULATORY COMPOUNDS
(FR) COMPOSES HEMOREGULATEURS
Abstract
(EN)
The present invention relates to novel compounds which have hemoregulatory activities and can be used to inhibit the myelopoietic system of humans and animals.
(FR)
L'invention concerne de nouveaux composés qui présentent une efficacité hémorégulatrice et peuvent s'utiliser afin d'inhiber le système myélopoïétique chez l'homme et chez l'animal.
Also published as
Latest bibliographic data on file with the International Bureau